J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 31.81 CNY 1.4% Market Closed
Market Cap: 25.7B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Jafron Biomedical Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jafron Biomedical Co Ltd
Interest Income Expense Peer Comparison

Comparables:
A
688617
J
002223
300760
L
300003
688271

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
J
Jafron Biomedical Co Ltd
SZSE:300529
Interest Income Expense
ÂĄ21.9m
CAGR 3-Years
-22%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Interest Income Expense
ÂĄ18m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Interest Income Expense
ÂĄ318.3m
CAGR 3-Years
N/A
CAGR 5-Years
47%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Interest Income Expense
ÂĄ804m
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Interest Income Expense
-ÂĄ82.5m
CAGR 3-Years
N/A
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Interest Income Expense
ÂĄ257.2m
CAGR 3-Years
190%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jafron Biomedical Co Ltd's Interest Income Expense?
Interest Income Expense
21.9m CNY

Based on the financial report for Jun 30, 2024, Jafron Biomedical Co Ltd's Interest Income Expense amounts to 21.9m CNY.

What is Jafron Biomedical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-12%

Over the last year, the Interest Income Expense growth was -5%. The average annual Interest Income Expense growth rates for Jafron Biomedical Co Ltd have been -22% over the past three years , -12% over the past five years .

Back to Top